The VEINS (Venous Endovascular INterventional Strategies) at VIVA is organized by Vascular Interventional Advances (VIVA) Physicians and will be held from Nov 02 - 04, 2019 at Wynn Las Vegas, Las Vegas, Nevada, United States of America.
Target Audience:
This activity has been designed for interventional cardiologists, vascular medicine specialists, interventional radiologists, vascular surgeons, neuroradiologists, podiatrists, internists, fellows, nurses, nurse practitioners, physician assistants, and technologists interested in exploring cutting-edge and future strategies for venous treatment, and those who are interested in a complete understanding of venous disease.
Accreditation:
The University at Buffalo Jacobs School of Medicine and Biomedical Sciences designates this live activity for a maximum of 18.75 AMA PRA Category 1 Credits™.
Program Overview:
The VEINS (Venous Endovascular INterventional Strategies) returns as a hands-on, interactive course focusing on pulmonary embolism treatment, controversies in VTE management, management of superficial venous disease, and late stage venous disease. Addressing the challenges of preventing, diagnosing, and managing venous disease, The VEINS will explore the complexities of caring for a diverse and growing patient population.
Learning Objectives:
Upon completion of the The VEINS, the targeted learners should be able to:
• Understand medical, endovascular, and surgical therapies for chronic venous disease.
• Appreciate the role of noninvasive technologies, including physiologic testing, duplex ultrasonography, and CT and MR venography, and invasive diagnostics, such as intravascular ultrasound, in the management of venous disease.
• Appreciate the available therapeutic options and understand contemporary data in the management of superficial and deep vein disease.
• Analyze the guidelines and available data and complications arising from the placement of IVC filters.
Additional details will be posted as soon as information is available.
Copyrights © 2026 eMedEvents Corporation, All Rights Reserved